# FDA recall D-1442-2012

> **Teva Pharmaceuticals USA, Inc.** · Class II · drug recall initiated 2012-05-18.

## Product

Copaxone (glatiramer acetate injection),  20mg/mL, 1 mL , Rx only, Marketed by: Teva Neuroscience - NDC 68546-317-30

## Reason for recall

Presence of Foreign Substance: Recall is being initiated due to the presence of a foreign particle identified from a customer complaint.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-1442-2012
- **Recalling firm:** Teva Pharmaceuticals USA, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2012-05-18
- **Report date:** 2012-08-15
- **Termination date:** 2013-04-11

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Sellersville, PA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1442-2012

## Citation

> AI Analytics. FDA recall D-1442-2012. Retrieved 2026-05-29 from https://api.ai-analytics.org/recall/D-1442-2012. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*